News

  Etripamil, an investigational drug, showed statistically significant reduction in ventricular rate by 30 beats per minute for episodes of atrial fibrillation with rapid ventricular rate (p < 0.0001) compared to...

Research presented at AHA Scientific Sessions 2023 associates vMap’s use with significantly improved outcomes for unstable VT and surgical ablation of ventricular arrhythmias

New study includes patients aged ≥65 years with atrial fibrillation (AF) at high risk for ischemic stroke or systemic embolism who are deemed ineligible for oral anticoagulant (OAC) treatment due to increased risk of...

The PREVENT risk calculator uniquely quantifies risks for CVD for each biological sex. As more research has been conducted specifically in women, this is an important way to understand their unique differences in CVD presentation and risk...

AHA23: Artificial intelligence (AI) applied to LINQ II™ ICMs reduce AF and pause (syncope) false alerts that can save clinics in the U.S. more than 400 hours per year

DALLAS – Measuring blood pressure while patients are standing rather than sitting may improve the accuracy of readings, UT Southwestern Medical Center researchers report. Their findings, published in Scientific Reports, could lead...

Patients reported improvements of 99% in control of AFib and 93.1% relief of symptoms with the QDOT MICRO™ Catheter. Temperature control allows for the use of higher radiofrequency power in short bursts, enhancing efficacy and efficiency...

PURE EP™ subscriber community now includes two of top three U.S. health systems in cardiology: Mayo Clinic-Phoenix and Cleveland Clinic

AI meets ECG to offer tailored insights for patients and clinicians, optimizing the path from hospital to home. InfoBionic CEO, Stuart Long, emphasizes their commitment to advanced remote monitoring, reducing costs, and improving patient...

Mount Sinai-Led Study is the First to Show There are No Sex Disparities in Patient Outcomes With This New Technology